In January 2026, the IMDEA Food Institute hosted the consortium’s Kick-Off Meeting, establishing a multidisciplinary alliance set to revolutionize venom-based drug discovery.
This open-access publication serves as a practical roadmap to help researchers navigate the complex landscape of intellectual property rights. While venom-derived compounds hold immense therapeutic potential, translating these laboratory discoveries into real-world applications requires a clear understanding of legal protection. The paper bridges this gap by clarifying what constitutes patentable subject matter and offering strategic guidance on how to secure innovations without compromising scientific collaboration.
This work is highly important for the scientific community because it directly supports the translation of cutting-edge toxinology into marketable healthcare solutions, ensuring that academic research successfully reaches industry stakeholders and, ultimately, patients.
The article is fully accessible to the public here:
